News & Events

Edgemont Capital Partners advises CroMedica, Inc. on merger with PRA International, Inc.

Press Release

PRA International Inc, a pharmaceutical research industry leader in contract clinical development services, today announced that it has agreed to a merger with CroMedica International, Inc, a worldwide clinical research organization (CRO) headquartered in Canada. The combined companies will operate under the PRA International name, forming one of the top five global clinical drug development organizations.